Page last updated: 2024-08-26

fluoromisonidazole and Neoplasms

fluoromisonidazole has been researched along with Neoplasms in 39 studies

Research

Studies (39)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (2.56)	18.7374
1990's	3 (7.69)	18.2507
2000's	13 (33.33)	29.6817
2010's	20 (51.28)	24.3611
2020's	2 (5.13)	2.80

Authors

Authors	Studies
Angermeier, A; Della Manna, D; Larimer, BM; Li, Y; Reeves, KM; Song, PN; Sorace, AG; Wang, J; Yang, ES	1
Higashikawa, K; Hirata, K; Kuge, Y; Magata, Y; Nakajima, K; Natsume, T; Ogawa, M; Sugikawa, A; Suzuki, C; Suzuki, M; Takahashi, S; Takakura, H; Tomita, M; Yasui, H	1
Booth, CJ; Carlson, DJ; Carson, RE; Decker, RH; Huang, Y; Kelada, OJ; Liu, Y; Oelfke, U; Rockwell, S; Zheng, MQ	1
Grimes, DR; Warren, DR; Warren, S	1
Hirata, K; Nagara, T; Shiga, T; Toyonaga, T	1
Asgari, H; Sefidgar, M; Soltani, M	1
Fukuda, K; Hanaoka, K; Hosono, M; Inada, M; Ishikawa, K; Kanamori, S; Nakamatsu, K; Nishimura, Y; Tachibana, I; Tatebe, H	1
Shimizu, Y	1
Krohn, KA; Rajendran, JG	1
Bezak, E; Jennings, M; Marcu, LG	1
Fink, JR; Krohn, KA; Mankoff, DA; McLaughlin, LJ; Muzi, JP; Muzi, M; O'Sullivan, JN; Peterson, LM; Rajendran, JG	1
Higashino, K; Kuge, Y; Masaki, Y; Nishijima, K; Numata, Y; Sakamoto, S; Shimizu, Y; Tamaki, N; Tanaka, Y; Yamaguchi, Y; Yoshioka, T; Zhao, S	1
Yoshimoto, M	1
Shi, K; Vaupel, P; Ziegler, SI	1
Partridge, M; Warren, DR	1
Chen, Q; Deng, X; He, F; Huang, Y; Li, GC; Ling, CC; Liu, Y; Minami, A; Sun, X; Wen, B; Xing, L; Zanzonico, PB	1
Bal, M; Georgi, JC; Humm, JL; Lee, NY; Narayanan, M; Nehmeh, SA; O'Donoghue, J; Paulus, T; Schmidtlein, CR; Wang, W; Zanzonico, PB	1
Hu, M; Xie, P; Yu, JM	1
Bradley, D; Dalah, E; Nisbet, A	1
Ball, C; Bejot, R; Carroll, L; Elizarov, AM; Gouverneur, V; Hill, S; Kelly, C; Kersemans, V; King, RC; Kolb, HC; Miraghaie, R; Smart, S; Zhang, J	1
Haubner, R	1
Bentzen, L; Buus, S; Keiding, S; Mortensen, LS; Munk, OL; Nordsmark, M; Overgaard, J	1
Barbet, J; Bourgeois, M; Cherel, M; Faivre-Chauvet, A; Guerard, F; Michel, N; Mougin-Degraef, M; Rajerison, H	1
Alber, M; Kaanders, JH; Mönnich, D; Oyen, WJ; Thorwarth, D; Troost, EG	1
Cheeseman, C; Khlebnikov, V; Kumar, P; Liang, H; Shustov, G; Wiebe, LI; Yang, XH; Zheng, W	1
Beck, R; Kumar, P; Machulla, HJ; McEwan, AJ; Picchio, M; Piert, M; Reischl, G; Schwaiger, M; Wester, HJ; Wiebe, LI; Ziegler, S	1
Burgman, P; Burnazi, E; Cai, S; Finn, RD; Humm, JL; Lewis, JS; Ling, CC; O'Donoghue, JA; Pugachev, A; Ruan, S; Smith-Jones, P; Welch, MJ; Wen, B; Zanzonico, P	1
Boerman, OC; Bussink, J; Kaanders, JH; Laverman, P; Lok, J; Oyen, WJ; Philippens, M; Troost, EG; van der Kogel, AJ	1
Blasberg, R; Humm, J; Ling, C; Serganova, I	1
Brady, M; Kelly, CJ	1
Kaanders, JH; Oyen, WJ; Schinagl, DA	1
Padhani, A	1
Chang, CW; Chen, CH; Chou, TK; Lin, WJ; Liu, RS; Wang, HE; Wang, SJ	1
Bergmann, R; Haase, C; Kampfrath, T; Mäding, P; Oswald, J; Pietzsch, J; Schwenzer, B; Treite, F	1
Lee, ST; Scott, AM	1
Casciari, JJ; Graham, MM; Rasey, JS	1
Cook, GJ; Fogelman, I	1
Avril, N; Schwaiger, M; Weber, WA	1
Bonasera, TA; Dence, CS; Hwang, DR; Welch, MJ	1

Reviews

12 review(s) available for fluoromisonidazole and Neoplasms

Article	Year
Hypoxia imaging and radiotherapy: bridging the resolution gap. The British journal of radiology, 2017, Volume: 90, Issue:1076 Topics: Cell Hypoxia; Humans; Hypoxia; Misonidazole; Neoplasms; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiotherapy Dosage	2017
[Accumulation Mechanism of 2-Nitroimidazole-based Hypoxia Imaging Probes Revealed by Imaging Mass Spectrometry]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2018, Volume: 138, Issue:11 Topics: Animals; Glutathione; Glutathione Transferase; Humans; Hypoxia; Mass Spectrometry; Mice; Misonidazole; Molecular Imaging; Molecular Probes; Multidrug Resistance-Associated Proteins; Neoplasms; Nitroimidazoles; Positron-Emission Tomography	2018
F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy. Seminars in nuclear medicine, 2015, Volume: 45, Issue:2 Topics: Animals; Cell Hypoxia; Humans; Misonidazole; Molecular Imaging; Neoplasms; Precision Medicine; Tumor Microenvironment	2015
PET-specific parameters and radiotracers in theoretical tumour modelling. Computational and mathematical methods in medicine, 2015, Volume: 2015 Topics: Cell Proliferation; Coordination Complexes; Dideoxynucleosides; Diffusion; Fluorodeoxyglucose F18; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glucose; Humans; Hydrogen-Ion Concentration; Hypoxia; Misonidazole; Models, Theoretical; Multimodal Imaging; Neoplasms; Neovascularization, Pathologic; Organometallic Compounds; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Thiosemicarbazones; Tomography, X-Ray Computed	2015
[Current Status and Prospects on PET Radiopharmaceuticals for Radiotherapy]. Igaku butsuri : Nihon Igaku Butsuri Gakkai kikanshi = Japanese journal of medical physics : an official journal of Japan Society of Medical Physics, 2015, Volume: 35, Issue:1 Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Coordination Complexes; Fluorine Radioisotopes; Humans; Hypoxia; Misonidazole; Neoplasms; Nitroimidazoles; Organometallic Compounds; Phenylalanine; Positron-Emission Tomography; Radiopharmaceuticals; Thiosemicarbazones	2015
[Advances in research on hypoxic imaging in cancer radiotherapy]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2009, Volume: 31, Issue:3 Topics: Cell Hypoxia; Humans; Misonidazole; Neoplasms; Positron-Emission Tomography; Radiography; Radiotherapy, Intensity-Modulated	2009
PET radiopharmaceuticals in radiation treatment planning - synthesis and biological characteristics. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2010, Volume: 96, Issue:3 Topics: Amino Acids; Biological Transport; Cell Hypoxia; Fluorodeoxyglucose F18; Glucose; Humans; Lipid Metabolism; Misonidazole; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Receptors, Somatostatin	2010
Contribution of [64Cu]-ATSM PET in molecular imaging of tumour hypoxia compared to classical [18F]-MISO--a selected review. Nuclear medicine review. Central & Eastern Europe, 2011, Volume: 14, Issue:2 Topics: Cell Hypoxia; Coordination Complexes; Copper Radioisotopes; Humans; Misonidazole; Neoplasms; Organometallic Compounds; Positron-Emission Tomography; Radiation-Sensitizing Agents; Thiosemicarbazones	2011
Tumor hypoxia imaging. Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Sep-15, Volume: 12, Issue:18 Topics: Biomarkers; Cell Hypoxia; Fluorodeoxyglucose F18; Humans; Misonidazole; Models, Biological; Neoplasm Metastasis; Neoplasms; Oxygen; Positron-Emission Tomography	2006
PET imaging of tumour hypoxia. Cancer imaging : the official publication of the International Cancer Imaging Society, 2006, Oct-31, Volume: 6 Topics: Cell Hypoxia; Coordination Complexes; Humans; Magnetic Resonance Imaging; Misonidazole; Neoplasms; Organometallic Compounds; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Thiosemicarbazones	2006
Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole. Seminars in nuclear medicine, 2007, Volume: 37, Issue:6 Topics: Animals; Brain Ischemia; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Fluorine Radioisotopes; Glioma; Head and Neck Neoplasms; Humans; Lung Neoplasms; Misonidazole; Myocardial Ischemia; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stroke	2007
Relevance of positron emission tomography (PET) in oncology. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1999, Volume: 175, Issue:8 Topics: Carbon Radioisotopes; Fluorides; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Methionine; Misonidazole; Neoplasm Staging; Neoplasms; Radioisotopes; Radiopharmaceuticals; Sensitivity and Specificity; Thymidine; Tomography, Emission-Computed; Tomography, X-Ray Computed	1999

Other Studies

27 other study(ies) available for fluoromisonidazole and Neoplasms

Article	Year
Clinical cancer research : an official journal of the American Association for Cancer Research, 2022, 01-15, Volume: 28, Issue:2 Topics: Cell Hypoxia; CTLA-4 Antigen; Humans; Hypoxia; Misonidazole; Neoplasms; Nitroimidazoles; Phosphoramide Mustards; Positron-Emission Tomography; Programmed Cell Death 1 Receptor; Tumor Microenvironment	2022
In vivo imaging of acute physiological responses after treatment of cancer with near-infrared photoimmunotherapy. Molecular imaging and biology, 2023, Volume: 25, Issue:4 Topics: Animals; Cell Line, Tumor; Fluorodeoxyglucose F18; Immunoconjugates; Immunotherapy; Mice; Neoplasms; Phototherapy; Xenograft Model Antitumor Assays	2023
Quantification of Tumor Hypoxic Fractions Using Positron Emission Tomography with [ Molecular imaging and biology, 2017, Volume: 19, Issue:6 Topics: Animals; Cell Hypoxia; Cell Line, Tumor; Humans; Kinetics; Male; Mice, Inbred BALB C; Misonidazole; Muscles; Neoplasms; Oxygen; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden	2017
Players of 'hypoxia orchestra' - what is the role of FMISO? European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:10 Topics: Humans; Misonidazole; Neoplasms; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Hypoxia	2017
Modeling of FMISO [F Microvascular research, 2018, Volume: 118 Topics: Blood Flow Velocity; Capillaries; Cell Hypoxia; Computer Simulation; Humans; Microcirculation; Misonidazole; Models, Cardiovascular; Nanoparticles; Neoplasms; Neovascularization, Pathologic; Numerical Analysis, Computer-Assisted; Oxygen; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Regional Blood Flow; Tumor Microenvironment	2018
Tumor Hypoxia Detected by Anticancer research, 2018, Volume: 38, Issue:3 Topics: Adult; Aged; Disease-Free Survival; Dose Fractionation, Radiation; Humans; Middle Aged; Misonidazole; Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; ROC Curve; Time Factors; Treatment Outcome; Tumor Hypoxia	2018
18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Aorta; Brain Neoplasms; Cerebellum; Disease Progression; Female; Heart; Humans; Hypoxia; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Neoplasms; Oxygen; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Tissue Distribution; Treatment Outcome	2015
The accumulation mechanism of the hypoxia imaging probe "FMISO" by imaging mass spectrometry: possible involvement of low-molecular metabolites. Scientific reports, 2015, Nov-19, Volume: 5 Topics: Animals; Diagnostic Imaging; Hypoxia; Male; Mass Spectrometry; Metabolome; Metabolomics; Mice, Inbred BALB C; Mice, Nude; Misonidazole; Molecular Probes; Molecular Weight; Neoplasms; Radionuclide Imaging; Reproducibility of Results; Tandem Mass Spectrometry; Tissue Distribution	2015
Molecular Imaging of Tumor Hypoxia: Existing Problems and Their Potential Model-Based Solutions. Advances in experimental medicine and biology, 2016, Volume: 923 Topics: Biomarkers, Tumor; Computer Simulation; Contrast Media; Diffusion; Humans; Microcirculation; Misonidazole; Models, Biological; Molecular Imaging; Neoplasms; Neovascularization, Pathologic; Oxygen; Phantoms, Imaging; Signal-To-Noise Ratio; Tumor Hypoxia; Tumor Microenvironment	2016
The role of necrosis, acute hypoxia and chronic hypoxia in Physics in medicine and biology, 2016, 12-21, Volume: 61, Issue:24 Topics: Computer Simulation; Humans; Hypoxia; Misonidazole; Models, Theoretical; Necrosis; Neoplasms; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Spheroids, Cellular	2016
Noninvasive molecular imaging of hypoxia in human xenografts: comparing hypoxia-induced gene expression with endogenous and exogenous hypoxia markers. Cancer research, 2008, Oct-15, Volume: 68, Issue:20 Topics: Animals; Antigens, Neoplasm; Arabinofuranosyluracil; Autoradiography; Biomarkers; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Hypoxia; Etanidazole; Female; Gene Expression; Green Fluorescent Proteins; Herpesvirus 1, Human; HT29 Cells; Humans; Hydrocarbons, Fluorinated; Immunohistochemistry; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Neoplasms; Nitroimidazoles; Positron-Emission Tomography; Thymidine Kinase; Tissue Distribution; Transplantation, Heterologous	2008
Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging. Physics in medicine and biology, 2009, May-21, Volume: 54, Issue:10 Topics: Algorithms; Computer Simulation; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Misonidazole; Models, Biological; Neoplasms; Oxygen; Oxygen Consumption; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2009
Simulation of tissue activity curves of (64)Cu-ATSM for sub-target volume delineation in radiotherapy. Physics in medicine and biology, 2010, Feb-07, Volume: 55, Issue:3 Topics: Algorithms; Blood Vessels; Cell Hypoxia; Computer Simulation; Contrast Media; Coordination Complexes; Copper Radioisotopes; Diffusion; Humans; Misonidazole; Models, Biological; Neoplasms; Organometallic Compounds; Oxygen; Positron-Emission Tomography; Radiotherapy; Radiotherapy Planning, Computer-Assisted; Thiosemicarbazones	2010
Pre-clinical evaluation of a 3-nitro-1,2,4-triazole analogue of [18F]FMISO as hypoxia-selective tracer for PET. Nuclear medicine and biology, 2010, Volume: 37, Issue:5 Topics: Animals; Biomarkers; Cell Hypoxia; Cell Line, Tumor; Cell Transformation, Neoplastic; Chemical Phenomena; Drug Evaluation, Preclinical; Female; Glutathione; Kinetics; Mice; Misonidazole; Models, Biological; Neoplasms; Oxidation-Reduction; Positron-Emission Tomography; Propanols; Radioactive Tracers; Triazoles; Xanthine Oxidase	2010
Identifying hypoxia in human tumors: A correlation study between 18F-FMISO PET and the Eppendorf oxygen-sensitive electrode. Acta oncologica (Stockholm, Sweden), 2010, Volume: 49, Issue:7 Topics: Biosensing Techniques; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Hypoxia; Microchemistry; Microelectrodes; Misonidazole; Neoplasms; Oxygen; Positron-Emission Tomography; Sarcoma; Soft Tissue Neoplasms	2010
Modelling and simulation of the influence of acute and chronic hypoxia on [18F]fluoromisonidazole PET imaging. Physics in medicine and biology, 2012, Mar-21, Volume: 57, Issue:6 Topics: Acute Disease; Chronic Disease; Computer Simulation; Fluorine Radioisotopes; Humans; Hypoxia; Misonidazole; Models, Biological; Neoplasms; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals	2012
Design, synthesis, and preliminary biological evaluation of 6-O-glucose-azomycin adducts for diagnosis and therapy of hypoxic tumors. Journal of medicinal chemistry, 2012, Jul-12, Volume: 55, Issue:13 Topics: Cell Hypoxia; Cell Line, Tumor; Drug Design; Glucose Transport Proteins, Facilitative; Glucosides; Glycosides; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Misonidazole; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents; Radionuclide Imaging; Radiopharmaceuticals; Transcriptional Activation	2012
Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005, Volume: 46, Issue:1 Topics: Animals; Cell Hypoxia; Disease Models, Animal; Female; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Nude; Misonidazole; Neoplasms; Nitroimidazoles; Organ Specificity; Oxidation-Reduction; Oxygen; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution	2005
Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent mic International journal of radiation oncology, biology, physics, 2005, Apr-01, Volume: 61, Issue:5 Topics: Animals; Autoradiography; Benzimidazoles; Cell Hypoxia; Coordination Complexes; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Microscopy, Fluorescence; Misonidazole; Neoplasms; Nitroimidazoles; Organometallic Compounds; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Rats; Rats, Nude; Thiosemicarbazones; Transplantation, Heterologous	2005
Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2006, Volume: 80, Issue:2 Topics: Animals; Autoradiography; Carcinoma, Squamous Cell; Cell Hypoxia; Fluorine Radioisotopes; Glioblastoma; Head and Neck Neoplasms; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Nude; Misonidazole; Neoplasms; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Radionuclide Imaging	2006
A model to simulate tumour oxygenation and dynamic [18F]-Fmiso PET data. Physics in medicine and biology, 2006, Nov-21, Volume: 51, Issue:22 Topics: Cell Hypoxia; Computer Simulation; Humans; Image Interpretation, Computer-Assisted; Misonidazole; Models, Biological; Neoplasms; Neovascularization, Pathologic; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals	2006
From anatomical to biological target volumes: the role of PET in radiation treatment planning. Cancer imaging : the official publication of the International Cancer Imaging Society, 2006, Oct-31, Volume: 6 Topics: Cell Hypoxia; Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Misonidazole; Neoplasms; Observer Variation; Patient Care Planning; Positron-Emission Tomography; Radiation Tolerance; Radiopharmaceuticals; Radiotherapy; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden	2006
A robotic synthesis of [18F]fluoromisonidazole ([18F]FMISO). Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2007, Volume: 65, Issue:6 Topics: Fluorine Radioisotopes; Hypoxia; Misonidazole; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Robotics	2007
Experimental hypoxia is a potent stimulus for radiotracer uptake in vitro: comparison of different tumor cells and primary endothelial cells. Cancer letters, 2007, Aug-28, Volume: 254, Issue:1 Topics: Cell Hypoxia; Cell Line; Cell Line, Tumor; Cells, Cultured; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gene Expression; HT29 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Misonidazole; Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Vascular Endothelial Growth Factor A	2007
A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data. Medical physics, 1995, Volume: 22, Issue:7 Topics: Animals; Biological Transport, Active; Biophysical Phenomena; Biophysics; Computer Simulation; Evaluation Studies as Topic; Humans; Hypoxia; Misonidazole; Models, Biological; Monte Carlo Method; Neoplasms; Radiation-Sensitizing Agents; Rats; Tomography, Emission-Computed	1995
Tumor hypoxia: the role of nuclear medicine. European journal of nuclear medicine, 1998, Volume: 25, Issue:4 Topics: Animals; Cell Hypoxia; Fluorine Radioisotopes; Humans; Misonidazole; Neoplasms; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	1998
No-carrier-added synthesis of 3-[18F]fluoro-1-(2-nitro-1-imidazolyl)-2-propanol. A potential PET agent for detecting hypoxic but viable tissues. International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes, 1989, Volume: 40, Issue:2 Topics: Fluorine Radioisotopes; Misonidazole; Neoplasms; Oxygen; Tomography, Emission-Computed	1989